SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-004104
Filing Date
2018-03-29
Accepted
2018-03-29 11:05:49
Documents
44
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 778851
2 ex10-21.htm EX-10.21 970
3 ex31-1.htm EX-31.1 16278
4 ex31-2.htm EX-31.2 16004
5 ex32-1.htm EX-32.1 8307
6 image_001.jpg GRAPHIC 3709
7 ex10-21_001.jpg GRAPHIC 90888
  Complete submission text file 0001493152-18-004104.txt   2111649

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE vapa-20171231.xml EX-101.INS 145969
9 XBRL SCHEMA FILE vapa-20171231.xsd EX-101.SCH 16383
10 XBRL CALCULATION FILE vapa-20171231_cal.xml EX-101.CAL 26071
11 XBRL DEFINITION FILE vapa-20171231_def.xml EX-101.DEF 80135
12 XBRL LABEL FILE vapa-20171231_lab.xml EX-101.LAB 141960
13 XBRL PRESENTATION FILE vapa-20171231_pre.xml EX-101.PRE 125043
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

IRS No.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55470 | Film No.: 18721334
SIC: 2834 Pharmaceutical Preparations